• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $DOMH

    Dominari Holdings Inc.

    Subscribe to $DOMH
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year:

    Exchange: NASDAQ

    Recent Analyst Ratings for Dominari Holdings Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    Dominari Holdings Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Dominari Holding's Strategic Interest in Bitcoin Mining Set to Go Public

      American Bitcoin Enters into Definitive Merger Agreement with Nasdaq-listed Gryphon Digital Mining to Build World's Largest, Most Efficient Pure-Play Bitcoin Minor Alongside A Robust and Strategic Bitcoin Reserve NEW YORK, May 13, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today congratulates American Bitcoin on entering into a definitive merger agreement with Gryphon Digital Mining, Inc. (NASDAQ:GRYP). The strategic stock-for-stock transaction will result in American Bitcoin becoming a publicly traded entity on Nasdaq in which former American Bitcoin stockholders, including Dominari Holdings, will own approximately 98% of the combined company.

      5/13/25 8:00:00 AM ET
      $DOMH
      $GRYP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      EDP Services
      Technology
    • authID Announces Pricing of Approximately $8,150,000 Million Registered Direct Offering

      DENVER, March 31, 2025 (GLOBE NEWSWIRE) -- authID Inc. (NASDAQ:AUID) ("authID" or the "Company"), a leading provider of biometric identity verification and authentication solutions, today announced it has entered into a definitive agreement with investors to sell approximately 1,811,111 shares  of its common stock (the "Shares") and/or Pre-Funded Warrants (the "Pre-Funded Warrants"), pursuant to a registered direct offering (the "Registered Direct Offering"). The purchase price for one Share or Pre-Funded Warrant will be $4.50, (each Pre-Funded Warrant will be exercisable into one share of common stock). The aggregate gross proceeds from the Offering are expected to be approximately $8,15

      3/31/25 8:30:00 AM ET
      $AUID
      $DJT
      $DOMH
      $DWAC
      Computer Software: Prepackaged Software
      Technology
      Computer Software: Programming Data Processing
      Biotechnology: Pharmaceutical Preparations
    • Dominari Holdings Investment, American Data Centers, Becomes American Bitcoin in Transformative Bitcoin Mining Deal with Hut 8

      Dominari Executing Expansion Strategy with Investment in Industrial Scale Bitcoin Mining and Bitcoin Reserve Development  NEW YORK, March 31, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced that American Data Centers Inc. ("ADC") and Hut 8 Corp, ("Hut") partnered to form American Bitcoin Corporation.  As previously announced, ADC was a wholly owned subsidiary of Dominari, but became an independent company, whose members include Donald J. Trump Jr., Eric Trump, Dominari and other industry professionals in the AI space.  In partnership with Hut, American Bitcoin Corp., will focus on industrial-scale bitcoin mining and strategic bitcoin reserve development and monetiza

      3/31/25 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Holdings Reports Preliminary FY 2024 Financial Results

      2024 Revenue Surges to Approximately $19 Million as Company Executes Growth and Expansion Strategy NEW YORK, March 28, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company" or "Dominari") today announced its preliminary, unaudited revenue results for the full year ended December 31, 2024. Based on preliminary financial data, Dominari expects to report total revenue of approximately $19 million for 2024, representing an approximately 900% increase compared to approximately $2.0 million in 2023. The Company had a strong fourth quarter in 2024 with over $8.0 mi

      3/28/25 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities Receives FINRA Approval to Expand Operations

      Parent Company Discusses Strategy to Evolve into a Broader Holding Company with a Focus on Emerging Technologies NEW YORK, March 4, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that its wholly-owned subsidiary, Dominari Securities LLC ("Dominari"), has received approval for its Continuing Membership Application ("CMA") from the Financial Industry Regulatory Authority ("FINRA"). The Company also provided additional commentary regarding its plans to develop into a broader holding company with a focus on emerging technologies. Dominari

      3/4/25 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Holdings Inc. Strengthens Team with Appointment of Experienced Accounting Team

      Edward Deignan Appointed as VP of Finance and Accounting Kyle Degruttola Appointed as Controller NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that it has appointed Edward Deignan as Vice President of Finance and Accounting and Kyle Degruttola as Controller. Together, they bring decades of accounting and finance leadership experience from various multi-national and public sector organizations.Mr. Deignan is responsible for the day-to-day management of the Company's financial operations. He brings with him more than 30 years of experience in accounting, finance and banking. He has served as a chief financial officer for s

      11/11/24 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities LLC Announces Appointment of Capital Markets Veteran James Hopkins as Managing Director Head of Capital Markets

      Hopkins has Led and Structured Hundreds of Capital Markets Transactions NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today noted that its wholly-owned subsidiary, Dominari Securities LLC ("Dominari"), announced that it has further expanded its practice with the appointment of capital markets veteran James (Jimmy) Hopkins as Managing Director Head of Capital Markets.Mr. Kyle Wool, CEO of Dominari Securities LLC, commented, "Our commitment to positioning Dominari as a full-service, diversified financial services firm and growing our business remains stronger than ever, and Jimmy has a proven record of success with hundreds of completed tran

      10/7/24 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities LLC Receives Milestone Approval as a Nasdaq Limited Underwriting Member

      NEW YORK CITY, NY / ACCESSWIRE / August 13, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that its wholly-owned subsidiary, Dominari Securities LLC ("Dominari"), has been approved as a Limited Underwriting Member of the Nasdaq Stock Market. This approval enables Dominari to act as a principal underwriter under Nasdaq Listing Rule 5210(m). Mr. Kyle Wool, CEO of Dominari, commented, "Being designated as a Limited Underwriting Member of Nasdaq is a notable achievement and key milestone in our business development strategy. The designation is an essential aspect for executing investment banking transactions and we believe it will help pave the way for growth in ou

      8/13/24 4:15:00 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities LLC Continues Expansion of Its Capital Market Group with Senior Hires

      Adds Capital Markets Expert and Best-Selling Author, Steve Kann and Strategic and Financial Advisory Veteran, Andre Peschong, as Managing DirectorsNEW YORK, NY / ACCESSWIRE / April 17, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today noted that its wholly-owned subsidiary, Dominari Securities LLC, announced that it has further expanded its practice with the addition of Steve Kann and Andre Peschong as Managing Directors.Mr. Kyle Wool, CEO of Dominari Securities LLC, commented, "The breadth and depth of experience that Steve and Andre bring to the team will be extremely valuable in helping us to realize our strategic vision of developing Dominari into a full-serve, diversifie

      4/17/24 8:30:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities Appoints 30 Year Financial Industry Expert to Manage Operations and Compliance

      Eric Newman Appointed as Executive Vice President  NEW YORK, March 15, 2024 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has appointed financial industry veteran, Eric Newman, to the role of Executive Vice President of Dominari Securities enriching the firm's investment banking expertise and bolstering its brokerage operations. Mr. Newman reports directly to CEO Kyle Wool and is responsible for managing the day-to-day aspects of the firm's broker-dealer operations, advising executive

      3/15/24 8:30:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Dominari Holdings Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Hayes Anthony gifted 15,000 shares, decreasing direct ownership by 0.92% to 1,614,566 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      5/6/25 4:15:04 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by President Wool Kyle Michael

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      4/16/25 7:55:12 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by CEO Hayes Anthony

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      4/16/25 7:54:31 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CEO Hayes Anthony was granted 154,559 shares, increasing direct ownership by 10% to 1,629,566 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      3/25/25 4:15:09 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • President Wool Kyle Michael was granted 154,559 shares, increasing direct ownership by 7% to 2,355,328 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      3/25/25 4:15:04 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CEO Hayes Anthony was granted 500,000 shares, increasing direct ownership by 51% to 1,475,007 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/20/25 9:21:27 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Lieberman Ronald J. was granted 150,000 shares, increasing direct ownership by 474% to 181,613 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/20/25 9:19:21 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Dudley Robert Frederick was granted 10,000 shares, increasing direct ownership by 81% to 22,411 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 5:07:30 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Ledwick Tim S bought 8,645 shares and was granted 10,000 shares, increasing direct ownership by 145% to 31,471 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 5:03:10 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Lieberman Ronald J. bought 21,613 shares and was granted 10,000 shares (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 5:00:46 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Dominari Holdings Inc. Financials

    Live finance-specific insights

    See more
    • Dominari Holdings Investment, American Data Centers, Becomes American Bitcoin in Transformative Bitcoin Mining Deal with Hut 8

      Dominari Executing Expansion Strategy with Investment in Industrial Scale Bitcoin Mining and Bitcoin Reserve Development  NEW YORK, March 31, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced that American Data Centers Inc. ("ADC") and Hut 8 Corp, ("Hut") partnered to form American Bitcoin Corporation.  As previously announced, ADC was a wholly owned subsidiary of Dominari, but became an independent company, whose members include Donald J. Trump Jr., Eric Trump, Dominari and other industry professionals in the AI space.  In partnership with Hut, American Bitcoin Corp., will focus on industrial-scale bitcoin mining and strategic bitcoin reserve development and monetiza

      3/31/25 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities Acquires Broker Team with $700 Million in Assets Under Management

      Firm Announces Five Day In Office Work Week NEW YORK, April 18, 2023 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that its wholly-owned subsidiary, Dominari Securities LLC, a FINRA licensed broker-dealer, has added an asset management team that manages over $700 million in client assets to its organization. This is the first significant acquisition since the division officially launched earlier this month after the purchase of the broker-dealer and registered investment adviser divisions of Fieldpoint Private Securities. Kyle Wool, CEO of Dominari Financial Inc. stated, "we are excited to have launched our broker-dealer division and are proudly open fo

      4/18/23 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Financial Inc. Acquires Leading Broker Dealer and Registered Investment Advisor Business

      Acquisition of Fieldpoint Private Securities Accelerates the Growth of the Company's Business with Launch of New Broker-Dealer and RIA Division NEW YORK, March 27, 2023 /PRNewswire/ -- Dominari Financial Inc., the financial services subsidiary of Dominari Holdings Inc., has announced the acquisition of the broker-dealer and registered investment advisor business of Fieldpoint Private Bank and Trust. The acquired business will be the foundation of a new financial services entity that will be known as Dominari Securities LLC. Fieldpoint Private Bank and Trust will continue to operate its Personal Banking and Commercial Banking entities under its name.

      3/27/23 5:35:00 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Dominari Holdings Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

      SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

      6/13/24 8:56:04 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

      SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

      6/13/24 4:32:07 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Dominari Holdings Inc. Leadership Updates

    Live Leadership Updates

    See more
    • Dominari Holdings Inc. Strengthens Team with Appointment of Experienced Accounting Team

      Edward Deignan Appointed as VP of Finance and Accounting Kyle Degruttola Appointed as Controller NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced that it has appointed Edward Deignan as Vice President of Finance and Accounting and Kyle Degruttola as Controller. Together, they bring decades of accounting and finance leadership experience from various multi-national and public sector organizations.Mr. Deignan is responsible for the day-to-day management of the Company's financial operations. He brings with him more than 30 years of experience in accounting, finance and banking. He has served as a chief financial officer for s

      11/11/24 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities LLC Announces Appointment of Capital Markets Veteran James Hopkins as Managing Director Head of Capital Markets

      Hopkins has Led and Structured Hundreds of Capital Markets Transactions NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today noted that its wholly-owned subsidiary, Dominari Securities LLC ("Dominari"), announced that it has further expanded its practice with the appointment of capital markets veteran James (Jimmy) Hopkins as Managing Director Head of Capital Markets.Mr. Kyle Wool, CEO of Dominari Securities LLC, commented, "Our commitment to positioning Dominari as a full-service, diversified financial services firm and growing our business remains stronger than ever, and Jimmy has a proven record of success with hundreds of completed tran

      10/7/24 8:00:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities Appoints 30 Year Financial Industry Expert to Manage Operations and Compliance

      Eric Newman Appointed as Executive Vice President  NEW YORK, March 15, 2024 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has appointed financial industry veteran, Eric Newman, to the role of Executive Vice President of Dominari Securities enriching the firm's investment banking expertise and bolstering its brokerage operations. Mr. Newman reports directly to CEO Kyle Wool and is responsible for managing the day-to-day aspects of the firm's broker-dealer operations, advising executive

      3/15/24 8:30:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities LLC Expands Investment Banking Practice with Appointment of Experienced Financial Executive

      Dr. Cosme Ordoñez Appointed Head of Investment Banking NEW YORK, March 12, 2024 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has appointed Dr. Cosme Ordoñez to the role of Head of Investment Banking, Investment Banking Principal and bolstering the firm's coverage in the healthcare sector. Dr. Ordoñez has more than 20 years of investment banking and healthcare experience. Most recently, he served as Senior Managing Director, Investment Banking at Aegis Capital in its private equity gr

      3/12/24 8:30:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Securities LLC Welcomes Another Wealth Management Team

      Adds seasoned Wealth Advisors, Michael Schiavello and Billy Takos, and team of 12 experienced wealth advisors NEW YORK, March 5, 2024 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today announced its wholly-owned subsidiary, Dominari Securities LLC, has further expanded its wealth management practice to include a team of 12 seasoned wealth advisors led by Mr. Michael Schiavello and Mr. Billy Takos.  Mr. Schiavello and Mr. Billy Takos will serve as Managing Directors and Co-Heads of Private Equity at Dominari Securities. With more than 60 years of combine

      3/5/24 8:30:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Holdings Appoints George Way Chief Financial Officer

      Experienced Finance Executive to Support Growth Strategy  NEW YORK, April 3, 2023 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) ("Dominari" or the "Company") today announced that George Way has been named Chief Financial Officer effective April 3, 2023.  Mr. Way brings more than 30 years of experience in finance, accounting, acquisitions and investments, and has a proven track record of solving complex business challenges. "George is a highly talented and accomplished finance executive with decades of experience that will be extremely valuable as we grow our financial s

      4/3/23 9:03:00 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Dominari Holdings Inc. SEC Filings

    See more
    • Dominari Holdings Inc. filed SEC Form 8-K: Leadership Update

      8-K - Dominari Holdings Inc. (0000012239) (Filer)

      5/23/25 4:15:22 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Dominari Holdings Inc. (0000012239) (Filer)

      5/13/25 8:15:21 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Dominari Holdings Inc.

      10-Q - Dominari Holdings Inc. (0000012239) (Filer)

      5/12/25 8:01:29 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Holdings Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - Dominari Holdings Inc. (0000012239) (Filer)

      4/30/25 5:15:08 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form EFFECT filed by Dominari Holdings Inc.

      EFFECT - Dominari Holdings Inc. (0000012239) (Filer)

      4/29/25 12:15:09 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form S-3 filed by Dominari Holdings Inc.

      S-3 - Dominari Holdings Inc. (0000012239) (Filer)

      4/18/25 5:38:47 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-K filed by Dominari Holdings Inc.

      10-K - Dominari Holdings Inc. (0000012239) (Filer)

      4/15/25 1:31:22 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Dominari Holdings Inc. (0000012239) (Filer)

      4/3/25 4:15:08 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - Dominari Holdings Inc. (0000012239) (Filer)

      3/31/25 8:23:08 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dominari Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Dominari Holdings Inc. (0000012239) (Filer)

      3/28/25 8:17:46 AM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Dominari Holdings Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ledwick Tim S bought 8,645 shares and was granted 10,000 shares, increasing direct ownership by 145% to 31,471 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 5:03:10 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Lieberman Ronald J. bought 21,613 shares and was granted 10,000 shares (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 5:00:46 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • President Wool Kyle Michael bought 288,184 shares, increasing direct ownership by 15% to 2,200,769 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 4:58:43 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Haug Kyle bought 14,409 shares and was granted 10,000 shares (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 4:56:17 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Blattner Gregory James bought 14,409 shares and was granted 10,000 shares, increasing direct ownership by 197% to 36,820 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 4:53:24 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • COO Devall Christopher Franklin was granted 351,851 shares and bought 28,818 shares, increasing direct ownership by 1,268% to 410,702 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 4:51:20 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CEO Hayes Anthony bought 288,184 shares, increasing direct ownership by 42% to 975,007 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      2/12/25 4:49:40 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Wool Kyle Michael bought $11,000 worth of shares (5,000 units at $2.20) (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      5/31/24 4:05:27 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Hayes Anthony bought $10,962 worth of shares (4,640 units at $2.36), increasing direct ownership by 2% to 223,146 units (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      5/31/24 4:05:29 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Wool Kyle Michael bought $25,390 worth of shares (8,500 units at $2.99) (SEC Form 4)

      4 - Dominari Holdings Inc. (0000012239) (Issuer)

      4/10/24 4:10:07 PM ET
      $DOMH
      Biotechnology: Pharmaceutical Preparations
      Health Care